Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Travere Therapeutics, Inc. has filed 1,280 SEC EDGAR filings since 27 Jun 2008

SEC filing history

Showing 576-600 of 1,000 matching filings.

Per page
25
Current page
24
4

FORM 4 SUBMISSION

Filing date
18 May 2021
Reporting date
14 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 May 2021
Reporting date
14 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 May 2021
Reporting date
14 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 May 2021
Reporting date
14 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 May 2021
Reporting date
14 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 May 2021
Reporting date
14 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 May 2021
Reporting date
14 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 May 2021
Reporting date
14 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 May 2021
Reporting date
11 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 May 2021
Reporting date
11 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 May 2021
Reporting date
11 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 May 2021
Reporting date
11 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 May 2021
Reporting date
11 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Apr 2021
Reporting date
16 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36257

DEF 14A

Filing date
16 Apr 2021
Reporting date
14 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-36257

PRE 14A

Filing date
06 Apr 2021
Reporting date
06 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Mar 2021
Reporting date
17 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 Feb 2021
Reporting date
17 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87088

SC 13G/A

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87088

SC 13G/A

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87088

CONSONANCE CAPITAL MANAGEMENT LP

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .